An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients.
Wei J, Rybczynska AA, Meng P, Terpstra M, Saber A, Sietzema J, Timens W, Schuuring E, Hiltermann TJN, Groen HJM, van der Wekken AJ, van den Berg A, Kok K.
Wei J, et al. Among authors: hiltermann tjn.
Cancers (Basel). 2020 Oct 1;12(10):2843. doi: 10.3390/cancers12102843.
Cancers (Basel). 2020.
PMID: 33019710
Free PMC article.